Chicago, June 10, 2024 – Vyaire Medical today announced Vyaire Holding Company and certain of its subsidiaries (Vyaire) have filed for Chapter 11 protection in the United States in order to obtain sufficient financing to continue business operations while Vyaire markets its business units for a value-maximizing sale. This decision follows below-plan performance in the first half of the financial year, which frustrated efforts to refinance company debt.

“Chapter 11 protection will offer us the breathing room we need to explore selling our businesses to capable, well-financed buyers that have the financial ability and stability to execute on the Respiratory Diagnostics (RDx) and Ventilation business strategies delivering our vital products to customers and patients in need,” said John Bibb, Group Chief Executive Officer, Vyaire.

“Our lenders continue to support our business, and we are working together to go through this process with as little disruption as possible to our customers and trusted partners.”

Vyaire remains open for business and, upon court approval, will have post-petition financing in hand to continue operations while in Chapter 11. In the coming months, the company will focus on:

• Supporting the continuity of services to customers and honoring commitments to partners and employees, while complying with the terms of the US Bankruptcy Code.
• Selling Vyaire business units to stable, well-capitalized buyers that will support the growth and development of our RDx and Ventilation portfolios.

“We remain committed to the success of our customers, our partners, and our employees and will continue to live out our core values in the work we do,” Bibb added. "Our plan is to maintain the team needed to operate safely and deliver effective healthcare solutions.“

The Chapter 11 filing only applies to Vyaire operations in the US and one non-operational international holding company. For more information, please visit the Vyaire case website: https://omniagentsolutions.com/Vyaire

_________________________________

Vyaire remains open for business and we are committed to our partnership with you. While in Chapter 11, we will continue to serve our customers and maintain the team needed to operate safely and efficiently. Our products remain available for purchase and our team remains available to assist you and your team. Standard regional limitations, outlined below, still apply.

About Vyaire Medical

Vyaire Medical Inc. is a global company focused exclusively on supporting breathing through every stage of life. Established from legacy brands with a 70-year history of pioneering breathing technology, the integrated solutions offered by the company’s Ventilation and Respiratory Diagnostics (RDx) businesses help enable, enhance, and extend lives. Vyaire products are available in more than 100 countries and are recognized, trusted, and preferred by specialists throughout the respiratory community worldwide.